When we injected therapeutic lentivirus to a human cell in vivo, then lentivirus infects host cells, meanwhile leave VSV-G and p26 protein on the surface of infected cells, whether host immune cell recognize viral proteins, then immune system kills cells with VSV-G and p26 that are infected by lentivirus.
In this way, in vivo lentivirus therapy is nearly less effective, because the immune cell will clean infected cells?